세계의 벤더 뉴트럴 아카이브(VNA) 및 PACS(의료영상저장전송시스템) 시장 규모, 점유율, 동향 분석 리포트 : 제품 유형별, 벤더 유형별, 도입별, 최종사용자별, 용도별, 모달리티별, 지역별, 전망과 예측(2024-2031년)

The Global Vendor Neutral Archive (VNA) & PACS Market size is expected to reach $8.3 billion by 2031, rising at a market growth of 9.3% CAGR during the forecast period.

In 2023, the Europe region generated 29% revenue share in the market. The European Union is working towards creating the European Health Data Space to improve data sharing and interoperability across member states. VNA systems are crucial for achieving the interoperability required for such initiatives by providing a standardized platform for managing diverse imaging data. European healthcare systems are pushing for medical imaging and data management standardization. PACS and VNA systems support this goal by enabling the integration of imaging data from various sources into a single, standardized platform.

The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In February, 2024, Hyland Software, Inc. announced the partnership with iTernity, a software company that enhances healthcare data storage. Their partnership integrates eternity iCAS FS with Hyland Healthcare's Acuo VNA, an advanced platform consolidating imaging data from various sources into a unified repository, supporting DICOM and multimedia formats for seamless integration. Moreover, In October, 2022, GE HealthCare Technologies, Inc. teamed up with Tribune Health, a Software company to enhance digital pathology with integrated solutions. The collaboration aims to merge Tribun's Health Suite data with GE's VNA, Edison Catalog, for a comprehensive patient record. This integration will improve pathology report accuracy, speed up diagnoses, and foster collaboration in oncology.

COVID 19 Impact Analysis

During the COVID-19 pandemic, the global supply chains for VNA and PACS systems experienced significant disruptions. Lockdowns, travel restrictions, and logistical challenges led to delays in delivering critical hardware components and system parts, affecting the ability to deploy and maintain these systems. Many VNA and PACS, hardware manufacturing facilities, faced temporary closures or reduced operations due to COVID-19. This resulted in delays in production schedules and supply shortages, impacting the availability of necessary components for system implementation. Thus, the COVID-19 pandemic had a negative impact on the market.

Market Growth Factors

Healthcare organizations increasingly seek unified platforms that allow for centralized medical data management. VNA solutions can store and manage imaging data from various modalities and departments in a single, accessible repository. This integration supports seamless data access and management across different healthcare settings, critical for comprehensive patient care. In conclusion, the rising demand for integrated healthcare systems and solutions drives the market's growth.

Additionally, Healthcare providers are using a variety of imaging modalities (e.g., MRI, CT scans, X-rays), each producing data in different formats. VNAs offer a standardized platform for storing and managing data from these diverse modalities, enabling seamless integration and access across different systems. This integration is crucial for ensuring that imaging data can be easily accessed and interpreted regardless of the source. Therefore, the growing need for interoperability and data sharing propels the market's growth.

Market Restraining Factors

VNA and PACS systems deployment requires substantial capital expenditure for hardware, software, and infrastructure. High-performance servers, storage systems, and network infrastructure are needed to support the complex requirements of these systems. The costs associated with acquiring and maintaining this infrastructure can be prohibitive, especially for smaller healthcare facilities and organizations. In conclusion, VNA and PACS solutions' high initial costs and implementation challenges are hindering the market's growth.

Product Type Outlook

Based on product type, the market is divided into VNA and PACS. In 2023, the PACS segment attained 43% revenue share in the market. Picture Archiving and Communication Systems (PACS) provide a centralized repository for medical imaging data. This centralization ensures that imaging data from various modalities and sources are stored in one location, making it easier for healthcare professionals to access and manage patient images.

Vendor Type Outlook

By vendor type, the market is divided into independent vendors and third-party vendors. The third-party vendor segment procured 40% revenue share in the market in 2023. Third-party vendors provide VNA and PACS solutions agnostic to specific imaging equipment or software providers. This neutrality allows for seamless integration with various existing systems from different manufacturers, enabling healthcare organizations to consolidate and manage their imaging data more effectively.

Deployment Outlook

Based on deployment mode, the market is categorized into on-premise, cloud-based, and hybrid model. In 2023, the cloud-based segment registered 32% revenue share in the market. Cloud-based solutions offer exceptional scalability, allowing healthcare organizations to expand their storage capacities in response to the increasing volumes of imaging data. This scalability ensures that cloud-based VNA and PACS systems can efficiently accommodate growing data needs without requiring significant upfront investment in physical infrastructure.

End User Outlook

On the basis of end user, the market is divided into hospitals & clinics, diagnostic centers, and others. The diagnostic centers segment held 21% revenue share in the market in 2023. Diagnostic centers increasingly rely on advanced imaging technologies and data management systems to enhance their services and improve patient care. The integration of VNA and PACS solutions enables these facilities to streamline their operations, facilitate collaboration with hospitals, and provide timely diagnostic insights.

Application Outlook

Based on application, the market is divided into cardiology, orthopedic, oncology, neurology, obstetrics & gynecology, and others. The oncology segment attained 22% revenue share in the market in 2023. Oncology involves using various imaging modalities, such as PET, CT, MRI, and ultrasound, to diagnose, stage, and monitor cancer. VNA and PACS systems are crucial for integrating these diverse imaging formats into a unified system, enabling comprehensive management and review of patient data across multiple modalities.

Modality Outlook

On the basis of modality, the market is segmented into computed tomography, mammography, MRI, ultrasound, X-rays, and PET. In 2023, the X-rays segment attained 22% revenue share in the market. X-ray imaging remains one of healthcare's most frequently used diagnostic tools due to its effectiveness in detecting various conditions, from fractures to infections. Daily, the high volume of X-ray images generated drives significant demand for storage and management solutions, such as VNA and PACS. X-rays are utilized in routine and emergency settings, making them a staple in medical imaging.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 39% revenue share in the market in 2023. North America, particularly the United States and Canada, boasts a highly advanced and sophisticated healthcare infrastructure. This development creates a robust environment for adopting advanced imaging solutions like VNA and PACS, integral to modern healthcare delivery. The healthcare sector in North America is quick to adopt new technologies.

Recent Strategies Deployed in the Market

• Feb-2024: Fujifilm Holdings Corporation unveiled Synapse VNA and Synapse Radiology PACS have been ranked #1 in the 2024 Best in KLAS Awards: Software and Services. This recognition highlights their excellence in diagnostic and enterprise imaging, helping healthcare organizations manage imaging data and enhance patient care across the healthcare ecosystem.
• Nov-2023: Hyland Software, Inc. unveiled its advanced diagnostic imaging and point-of-care solutions at this year's RSNA conference. The company aims to address healthcare challenges like staff shortages and increasing demand by offering technologies that enhance patient information and decision-making.
• Feb-2023: Fujifilm Holdings Corporation announced the acquisition of Inspirata's global digital pathology business, including the Dynamyx system. This acquisition strengthens Fujifilm's healthcare capabilities, enhancing collaboration between pathology, radiology, and oncology, and improving integrated care delivery across the enterprise. Inspirata is a Tampa-based company specializing in cancer informatics.
• Sep-2022: IBM Corporation unveiled data, analytics, and technology solutions for the health industry. Their Enterprise Imaging solutions include IBM iConnect Access, a zero-download image viewer, IBM iConnect Enterprise Archive, a VNA, and Merge PACS, an AI-ready workflow platform.
• Apr-2022: Koninklijke Philips N.V. teamed up with Prisma Health, an 814-bed tertiary referral hospital and academic center to enhance enterprise interoperability, standardize patient monitoring, and drive innovation in enterprise imaging solutions. This collaboration aims to improve patient care, and clinical performance, and achieve the quadruple aim: better satisfaction, lower costs, and enhanced outcomes for South Carolinians.

List of Key Companies Profiled

• Hyland Software, Inc.
• GE HealthCare Technologies, Inc.
• Koninklijke Philips N.V.
• Siemens Healthineers AG (Siemens AG)
• Fujifilm Holdings Corporation
• IBM Corporation
• Carestream Health, Inc. (Onex Corporation)
• Novarad Enterprise Healthcare Solutions
• Canon, Inc. (Canon Medical Systems Corporation)
• INFINITT Healthcare Co. Ltd.

Global Vendor Neutral Archive (VNA) & PACS Market Report Segmentation

By Product Type

• VNA
  • Multi-Department VNA
  • Department VNA
  • Multi-Site VNA
• PACS
  • Multi-Department PACS
  • Department PACS
  • Multi-Site PACS

By Vendor Type

• Independent Vendor
• Third-party Vendor

By Deployment

• On-Premise
• Cloud-Based
• Hybrid Model

By End User

• Hospitals & Clinics
• Diagnostic Centers
• Others

By Application

• Cardiology
• Orthopedic
• Oncology
• Neurology
• Obstetrics & Gynecology
• Others

By Modality

• Computed Tomography
• Mammography
• MRI
• Ultrasound
• X-Rays
• PET

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
• Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Vendor Neutral Archive (VNA) & PACS Market, by Product Type
  • 1.4.2 Global Vendor Neutral Archive (VNA) & PACS Market, by Vendor Type
  • 1.4.3 Global Vendor Neutral Archive (VNA) & PACS Market, by Deployment
  • 1.4.4 Global Vendor Neutral Archive (VNA) & PACS Market, by End User
  • 1.4.5 Global Vendor Neutral Archive (VNA) & PACS Market, by Application
  • 1.4.6 Global Vendor Neutral Archive (VNA) & PACS Market, by Modality
  • 1.4.7 Global Vendor Neutral Archive (VNA) & PACS Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

• 4.1 KBV Cardinal Matrix
• 4.2 Recent Industry Wide Strategic Developments
  • 4.2.1 Partnerships, Collaborations and Agreements
  • 4.2.2 Product Launches and Product Expansions
  • 4.2.3 Acquisition and Mergers
• 4.3 Market Share Analysis, 2023
• 4.4 Top Winning Strategies
  • 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
  • 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2020, Aug - 2024, Feb) Leading Players
• 4.5 Porter Five Forces Analysis

Chapter 5. Global Vendor Neutral Archive (VNA) & PACS Market by Product Type

• 5.1 Global VNA Market by Region
• 5.2 Global Vendor Neutral Archive (VNA) & PACS Market by VNA Type
  • 5.2.1 Global Multi-Department VNA Market by Region
  • 5.2.2 Global Department VNA Market by Region
  • 5.2.3 Global Multi-Site VNA Market by Region
• 5.3 Global PACS Market by Region
• 5.4 Global Vendor Neutral Archive (VNA) & PACS Market by PACS Type
  • 5.4.1 Global Multi-Department PACS Market by Region
  • 5.4.2 Global Department PACS Market by Region
  • 5.4.3 Global Multi-Site PACS Market by Region

Chapter 6. Global Vendor Neutral Archive (VNA) & PACS Market by Vendor Type

• 6.1 Global Independent Vendor Market by Region
• 6.2 Global Third-party Vendor Market by Region

Chapter 7. Global Vendor Neutral Archive (VNA) & PACS Market by Deployment

• 7.1 Global On-Premise Market by Region
• 7.2 Global Cloud-Based Market by Region
• 7.3 Global Hybrid Model Market by Region

Chapter 8. Global Vendor Neutral Archive (VNA) & PACS Market by End User

• 8.1 Global Hospitals & Clinics Market by Region
• 8.2 Global Diagnostic Centers Market by Region
• 8.3 Global Others Market by Region

Chapter 9. Global Vendor Neutral Archive (VNA) & PACS Market by Application

• 9.1 Global Cardiology Market by Region
• 9.2 Global Orthopedic Market by Region
• 9.3 Global Oncology Market by Region
• 9.4 Global Neurology Market by Region
• 9.5 Global Obstetrics & Gynecology Market by Region
• 9.6 Global Others Market by Region

Chapter 10. Global Vendor Neutral Archive (VNA) & PACS Market by Modality

• 10.1 Global Computed Tomography Market by Region
• 10.2 Global Mammography Market by Region
• 10.3 Global MRI Market by Region
• 10.4 Global Ultrasound Market by Region
• 10.5 Global X-Rays Market by Region
• 10.6 Global PET Market by Region

Chapter 11. Global Vendor Neutral Archive (VNA) & PACS Market by Region

• 11.1 North America Vendor Neutral Archive (VNA) & PACS Market
  • 11.1.1 North America Vendor Neutral Archive (VNA) & PACS Market by Product Type
    • 11.1.1.1 North America VNA Market by Region
    • 11.1.1.2 North America Vendor Neutral Archive (VNA) & PACS Market by VNA Type
      • 11.1.1.2.1 North America Multi-Department VNA Market by Country
      • 11.1.1.2.2 North America Department VNA Market by Country
      • 11.1.1.2.3 North America Multi-Site VNA Market by Country
    • 11.1.1.3 North America PACS Market by Region
    • 11.1.1.4 North America Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.1.1.4.1 North America Multi-Department PACS Market by Country
      • 11.1.1.4.2 North America Department PACS Market by Country
      • 11.1.1.4.3 North America Multi-Site PACS Market by Country
  • 11.1.2 North America Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
    • 11.1.2.1 North America Independent Vendor Market by Region
    • 11.1.2.2 North America Third-party Vendor Market by Region
  • 11.1.3 North America Vendor Neutral Archive (VNA) & PACS Market by Deployment
    • 11.1.3.1 North America On-Premise Market by Country
    • 11.1.3.2 North America Cloud-Based Market by Country
    • 11.1.3.3 North America Hybrid Model Market by Country
  • 11.1.4 North America Vendor Neutral Archive (VNA) & PACS Market by End User
    • 11.1.4.1 North America Hospitals & Clinics Market by Country
    • 11.1.4.2 North America Diagnostic Centers Market by Country
    • 11.1.4.3 North America Others Market by Country
  • 11.1.5 North America Vendor Neutral Archive (VNA) & PACS Market by Application
    • 11.1.5.1 North America Cardiology Market by Country
    • 11.1.5.2 North America Orthopedic Market by Country
    • 11.1.5.3 North America Oncology Market by Country
    • 11.1.5.4 North America Neurology Market by Country
    • 11.1.5.5 North America Obstetrics & Gynecology Market by Country
    • 11.1.5.6 North America Others Market by Country
  • 11.1.6 North America Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.1.6.1 North America Computed Tomography Market by Country
    • 11.1.6.2 North America Mammography Market by Country
    • 11.1.6.3 North America MRI Market by Country
    • 11.1.6.4 North America Ultrasound Market by Country
    • 11.1.6.5 North America X-Rays Market by Country
    • 11.1.6.6 North America PET Market by Country
  • 11.1.7 North America Vendor Neutral Archive (VNA) & PACS Market by Country
    • 11.1.7.1 US Vendor Neutral Archive (VNA) & PACS Market
      • 11.1.7.1.1 US Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.1.7.1.1.1 US Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.1.7.1.1.2 US Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.1.7.1.2 US Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.1.7.1.3 US Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.1.7.1.4 US Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.1.7.1.5 US Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.1.7.1.6 US Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.1.7.2 Canada Vendor Neutral Archive (VNA) & PACS Market
      • 11.1.7.2.1 Canada Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.1.7.2.1.1 Canada Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.1.7.2.1.2 Canada Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.1.7.2.2 Canada Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.1.7.2.3 Canada Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.1.7.2.4 Canada Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.1.7.2.5 Canada Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.1.7.2.6 Canada Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.1.7.3 Mexico Vendor Neutral Archive (VNA) & PACS Market
      • 11.1.7.3.1 Mexico Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.1.7.3.1.1 Mexico Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.1.7.3.1.2 Mexico Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.1.7.3.2 Mexico Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.1.7.3.3 Mexico Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.1.7.3.4 Mexico Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.1.7.3.5 Mexico Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.1.7.3.6 Mexico Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.1.7.4 Rest of North America Vendor Neutral Archive (VNA) & PACS Market
      • 11.1.7.4.1 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.1.7.4.1.1 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.1.7.4.1.2 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.1.7.4.2 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.1.7.4.3 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.1.7.4.4 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.1.7.4.5 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.1.7.4.6 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Modality
• 11.2 Europe Vendor Neutral Archive (VNA) & PACS Market
  • 11.2.1 Europe Vendor Neutral Archive (VNA) & PACS Market by Product Type
    • 11.2.1.1 Europe VNA Market by Country
    • 11.2.1.2 Europe Vendor Neutral Archive (VNA) & PACS Market by VNA Type
      • 11.2.1.2.1 Europe Multi-Department VNA Market by Country
      • 11.2.1.2.2 Europe Department VNA Market by Country
      • 11.2.1.2.3 Europe Multi-Site VNA Market by Country
    • 11.2.1.3 Europe PACS Market by Country
    • 11.2.1.4 Europe Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.2.1.4.1 Europe Multi-Department PACS Market by Country
      • 11.2.1.4.2 Europe Department PACS Market by Country
      • 11.2.1.4.3 Europe Multi-Site PACS Market by Country
  • 11.2.2 Europe Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
    • 11.2.2.1 Europe Independent Vendor Market by Country
    • 11.2.2.2 Europe Third-party Vendor Market by Country
  • 11.2.3 Europe Vendor Neutral Archive (VNA) & PACS Market by Deployment
    • 11.2.3.1 Europe On-Premise Market by Country
    • 11.2.3.2 Europe Cloud-Based Market by Country
    • 11.2.3.3 Europe Hybrid Model Market by Country
  • 11.2.4 Europe Vendor Neutral Archive (VNA) & PACS Market by End User
    • 11.2.4.1 Europe Hospitals & Clinics Market by Country
    • 11.2.4.2 Europe Diagnostic Centers Market by Country
    • 11.2.4.3 Europe Others Market by Country
  • 11.2.5 Europe Vendor Neutral Archive (VNA) & PACS Market by Application
    • 11.2.5.1 Europe Cardiology Market by Country
    • 11.2.5.2 Europe Orthopedic Market by Country
    • 11.2.5.3 Europe Oncology Market by Country
    • 11.2.5.4 Europe Neurology Market by Country
    • 11.2.5.5 Europe Obstetrics & Gynecology Market by Country
    • 11.2.5.6 Europe Others Market by Country
  • 11.2.6 Europe Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.2.6.1 Europe Computed Tomography Market by Country
    • 11.2.6.2 Europe Mammography Market by Country
    • 11.2.6.3 Europe MRI Market by Country
    • 11.2.6.4 Europe Ultrasound Market by Country
    • 11.2.6.5 Europe X-Rays Market by Country
    • 11.2.6.6 Europe PET Market by Country
  • 11.2.7 Europe Vendor Neutral Archive (VNA) & PACS Market by Country
    • 11.2.7.1 Germany Vendor Neutral Archive (VNA) & PACS Market
      • 11.2.7.1.1 Germany Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.2.7.1.1.1 Germany Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.2.7.1.1.2 Germany Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.2.7.1.2 Germany Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.2.7.1.3 Germany Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.2.7.1.4 Germany Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.2.7.1.5 Germany Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.2.7.1.6 Germany Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.2.7.2 UK Vendor Neutral Archive (VNA) & PACS Market
      • 11.2.7.2.1 UK Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.2.7.2.1.1 UK Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.2.7.2.1.2 UK Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.2.7.2.2 UK Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.2.7.2.3 UK Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.2.7.2.4 UK Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.2.7.2.5 UK Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.2.7.2.6 UK Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.2.7.3 France Vendor Neutral Archive (VNA) & PACS Market
      • 11.2.7.3.1 France Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.2.7.3.1.1 France Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.2.7.3.1.2 France Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.2.7.3.2 France Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.2.7.3.3 France Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.2.7.3.4 France Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.2.7.3.5 France Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.2.7.3.6 France Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.2.7.4 Russia Vendor Neutral Archive (VNA) & PACS Market
      • 11.2.7.4.1 Russia Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.2.7.4.1.1 Russia Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.2.7.4.1.2 Russia Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.2.7.4.2 Russia Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.2.7.4.3 Russia Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.2.7.4.4 Russia Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.2.7.4.5 Russia Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.2.7.4.6 Russia Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.2.7.5 Spain Vendor Neutral Archive (VNA) & PACS Market
      • 11.2.7.5.1 Spain Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.2.7.5.1.1 Spain Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.2.7.5.1.2 Spain Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.2.7.5.2 Spain Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.2.7.5.3 Spain Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.2.7.5.4 Spain Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.2.7.5.5 Spain Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.2.7.5.6 Spain Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.2.7.6 Italy Vendor Neutral Archive (VNA) & PACS Market
      • 11.2.7.6.1 Italy Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.2.7.6.1.1 Italy Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.2.7.6.1.2 Italy Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.2.7.6.2 Italy Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.2.7.6.3 Italy Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.2.7.6.4 Italy Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.2.7.6.5 Italy Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.2.7.6.6 Italy Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.2.7.7 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market
      • 11.2.7.7.1 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.2.7.7.1.1 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.2.7.7.1.2 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.2.7.7.2 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.2.7.7.3 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.2.7.7.4 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.2.7.7.5 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.2.7.7.6 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Modality
• 11.3 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market
  • 11.3.1 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Product Type
    • 11.3.1.1 Asia Pacific VNA Market by Country
    • 11.3.1.2 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by VNA Type
      • 11.3.1.2.1 Asia Pacific Multi-Department VNA Market by Country
      • 11.3.1.2.2 Asia Pacific Department VNA Market by Country
      • 11.3.1.2.3 Asia Pacific Multi-Site VNA Market by Country
    • 11.3.1.3 Asia Pacific PACS Market by Country
    • 11.3.1.4 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.3.1.4.1 Asia Pacific Multi-Department PACS Market by Country
      • 11.3.1.4.2 Asia Pacific Department PACS Market by Country
      • 11.3.1.4.3 Asia Pacific Multi-Site PACS Market by Country
  • 11.3.2 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
    • 11.3.2.1 Asia Pacific Independent Vendor Market by Country
    • 11.3.2.2 Asia Pacific Third-party Vendor Market by Country
  • 11.3.3 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Deployment
    • 11.3.3.1 Asia Pacific On-Premise Market by Country
    • 11.3.3.2 Asia Pacific Cloud-Based Market by Country
    • 11.3.3.3 Asia Pacific Hybrid Model Market by Country
  • 11.3.4 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by End User
    • 11.3.4.1 Asia Pacific Hospitals & Clinics Market by Country
    • 11.3.4.2 Asia Pacific Diagnostic Centers Market by Country
    • 11.3.4.3 Asia Pacific Others Market by Country
  • 11.3.5 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Application
    • 11.3.5.1 Asia Pacific Cardiology Market by Country
    • 11.3.5.2 Asia Pacific Orthopedic Market by Country
    • 11.3.5.3 Asia Pacific Oncology Market by Country
    • 11.3.5.4 Asia Pacific Neurology Market by Country
    • 11.3.5.5 Asia Pacific Obstetrics & Gynecology Market by Country
    • 11.3.5.6 Asia Pacific Others Market by Country
  • 11.3.6 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.3.6.1 Asia Pacific Computed Tomography Market by Country
    • 11.3.6.2 Asia Pacific Mammography Market by Country
    • 11.3.6.3 Asia Pacific MRI Market by Country
    • 11.3.6.4 Asia Pacific Ultrasound Market by Country
    • 11.3.6.5 Asia Pacific X-Rays Market by Country
    • 11.3.6.6 Asia Pacific PET Market by Country
  • 11.3.7 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Country
    • 11.3.7.1 China Vendor Neutral Archive (VNA) & PACS Market
      • 11.3.7.1.1 China Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.3.7.1.1.1 China Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.3.7.1.1.2 China Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.3.7.1.2 China Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.3.7.1.3 China Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.3.7.1.4 China Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.3.7.1.5 China Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.3.7.1.6 China Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.3.7.2 Japan Vendor Neutral Archive (VNA) & PACS Market
      • 11.3.7.2.1 Japan Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.3.7.2.1.1 Japan Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.3.7.2.1.2 Japan Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.3.7.2.2 Japan Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.3.7.2.3 Japan Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.3.7.2.4 Japan Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.3.7.2.5 Japan Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.3.7.2.6 Japan Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.3.7.3 India Vendor Neutral Archive (VNA) & PACS Market
      • 11.3.7.3.1 India Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.3.7.3.1.1 India Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.3.7.3.1.2 India Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.3.7.3.2 India Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.3.7.3.3 India Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.3.7.3.4 India Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.3.7.3.5 India Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.3.7.3.6 India Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.3.7.4 South Korea Vendor Neutral Archive (VNA) & PACS Market
      • 11.3.7.4.1 South Korea Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.3.7.4.1.1 South Korea Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.3.7.4.1.2 South Korea Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.3.7.4.2 South Korea Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.3.7.4.3 South Korea Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.3.7.4.4 South Korea Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.3.7.4.5 South Korea Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.3.7.4.6 South Korea Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.3.7.5 Singapore Vendor Neutral Archive (VNA) & PACS Market
      • 11.3.7.5.1 Singapore Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.3.7.5.1.1 Singapore Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.3.7.5.1.2 Singapore Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.3.7.5.2 Singapore Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.3.7.5.3 Singapore Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.3.7.5.4 Singapore Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.3.7.5.5 Singapore Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.3.7.5.6 Singapore Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.3.7.6 Malaysia Vendor Neutral Archive (VNA) & PACS Market
      • 11.3.7.6.1 Malaysia Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.3.7.6.1.1 Malaysia Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.3.7.6.1.2 Malaysia Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.3.7.6.2 Malaysia Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.3.7.6.3 Malaysia Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.3.7.6.4 Malaysia Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.3.7.6.5 Malaysia Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.3.7.6.6 Malaysia Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.3.7.7 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market
      • 11.3.7.7.1 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.3.7.7.1.1 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.3.7.7.1.2 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.3.7.7.2 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.3.7.7.3 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.3.7.7.4 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.3.7.7.5 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.3.7.7.6 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Modality
• 11.4 LAMEA Vendor Neutral Archive (VNA) & PACS Market
  • 11.4.1 LAMEA Vendor Neutral Archive (VNA) & PACS Market by Product Type
    • 11.4.1.1 LAMEA VNA Market by Country
    • 11.4.1.2 LAMEA Vendor Neutral Archive (VNA) & PACS Market by VNA Type
      • 11.4.1.2.1 LAMEA Multi-Department VNA Market by Country
      • 11.4.1.2.2 LAMEA Department VNA Market by Country
      • 11.4.1.2.3 LAMEA Multi-Site VNA Market by Country
    • 11.4.1.3 LAMEA PACS Market by Country
    • 11.4.1.4 LAMEA Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.4.1.4.1 LAMEA Multi-Department PACS Market by Country
      • 11.4.1.4.2 LAMEA Department PACS Market by Country
      • 11.4.1.4.3 LAMEA Multi-Site PACS Market by Country
  • 11.4.2 LAMEA Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
    • 11.4.2.1 LAMEA Independent Vendor Market by Country
    • 11.4.2.2 LAMEA Third-party Vendor Market by Country
  • 11.4.3 LAMEA Vendor Neutral Archive (VNA) & PACS Market by Deployment
    • 11.4.3.1 LAMEA On-Premise Market by Country
    • 11.4.3.2 LAMEA Cloud-Based Market by Country
    • 11.4.3.3 LAMEA Hybrid Model Market by Country
  • 11.4.4 LAMEA Vendor Neutral Archive (VNA) & PACS Market by End User
    • 11.4.4.1 LAMEA Hospitals & Clinics Market by Country
    • 11.4.4.2 LAMEA Diagnostic Centers Market by Country
    • 11.4.4.3 LAMEA Others Market by Country
  • 11.4.5 LAMEA Vendor Neutral Archive (VNA) & PACS Market by Application
    • 11.4.5.1 LAMEA Cardiology Market by Country
    • 11.4.5.2 LAMEA Orthopedic Market by Country
    • 11.4.5.3 LAMEA Oncology Market by Country
    • 11.4.5.4 LAMEA Neurology Market by Country
    • 11.4.5.5 LAMEA Obstetrics & Gynecology Market by Country
    • 11.4.5.6 LAMEA Others Market by Country
  • 11.4.6 LAMEA Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.4.6.1 LAMEA Computed Tomography Market by Country
    • 11.4.6.2 LAMEA Mammography Market by Country
    • 11.4.6.3 LAMEA MRI Market by Country
    • 11.4.6.4 LAMEA Ultrasound Market by Country
    • 11.4.6.5 LAMEA X-Rays Market by Country
    • 11.4.6.6 LAMEA PET Market by Country
  • 11.4.7 LAMEA Vendor Neutral Archive (VNA) & PACS Market by Country
    • 11.4.7.1 Brazil Vendor Neutral Archive (VNA) & PACS Market
      • 11.4.7.1.1 Brazil Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.4.7.1.1.1 Brazil Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.4.7.1.1.2 Brazil Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.4.7.1.2 Brazil Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.4.7.1.3 Brazil Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.4.7.1.4 Brazil Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.4.7.1.5 Brazil Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.4.7.1.6 Brazil Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.4.7.2 Argentina Vendor Neutral Archive (VNA) & PACS Market
      • 11.4.7.2.1 Argentina Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.4.7.2.1.1 Argentina Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.4.7.2.1.2 Argentina Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.4.7.2.2 Argentina Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.4.7.2.3 Argentina Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.4.7.2.4 Argentina Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.4.7.2.5 Argentina Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.4.7.2.6 Argentina Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.4.7.3 UAE Vendor Neutral Archive (VNA) & PACS Market
      • 11.4.7.3.1 UAE Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.4.7.3.1.1 UAE Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.4.7.3.1.2 UAE Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.4.7.3.2 UAE Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.4.7.3.3 UAE Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.4.7.3.4 UAE Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.4.7.3.5 UAE Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.4.7.3.6 UAE Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.4.7.4 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market
      • 11.4.7.4.1 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.4.7.4.1.1 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.4.7.4.1.2 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.4.7.4.2 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.4.7.4.3 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.4.7.4.4 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.4.7.4.5 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.4.7.4.6 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.4.7.5 South Africa Vendor Neutral Archive (VNA) & PACS Market
      • 11.4.7.5.1 South Africa Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.4.7.5.1.1 South Africa Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.4.7.5.1.2 South Africa Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.4.7.5.2 South Africa Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.4.7.5.3 South Africa Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.4.7.5.4 South Africa Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.4.7.5.5 South Africa Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.4.7.5.6 South Africa Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.4.7.6 Nigeria Vendor Neutral Archive (VNA) & PACS Market
      • 11.4.7.6.1 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.4.7.6.1.1 Nigeria Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.4.7.6.1.2 Nigeria Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.4.7.6.2 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.4.7.6.3 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.4.7.6.4 Nigeria Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.4.7.6.5 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.4.7.6.6 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Modality
    • 11.4.7.7 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market
      • 11.4.7.7.1 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Product Type
        • 11.4.7.7.1.1 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by VNA Type
        • 11.4.7.7.1.2 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by PACS Type
      • 11.4.7.7.2 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
      • 11.4.7.7.3 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Deployment
      • 11.4.7.7.4 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by End User
      • 11.4.7.7.5 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Application
      • 11.4.7.7.6 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Modality

Chapter 12. Company Profiles

• 12.1 Hyland Software, Inc.
  • 12.1.1 Company Overview
  • 12.1.2 Recent strategies and developments:
    • 12.1.2.1 Partnerships, Collaborations, and Agreements:
    • 12.1.2.2 Product Launches and Product Expansions:
• 12.2 GE HealthCare Technologies, Inc.
  • 12.2.1 Company Overview
  • 12.2.2 Financial Analysis
  • 12.2.3 Segmental and Regional Analysis
  • 12.2.4 Research & Development Expenses
  • 12.2.5 Recent strategies and developments:
    • 12.2.5.1 Partnerships, Collaborations, and Agreements:
  • 12.2.6 SWOT Analysis
• 12.3 Koninklijke Philips N.V.
  • 12.3.1 Company Overview
  • 12.3.2 Financial Analysis
  • 12.3.3 Segmental and Regional Analysis
  • 12.3.4 Research & Development Expense
  • 12.3.5 Recent strategies and developments:
    • 12.3.5.1 Partnerships, Collaborations, and Agreements:
  • 12.3.6 SWOT Analysis
• 12.4 Siemens Healthineers AG (Siemens AG)
  • 12.4.1 Company Overview
  • 12.4.2 Financial Analysis
  • 12.4.3 Segmental and Regional Analysis
  • 12.4.4 Research & Development Expense
  • 12.4.5 Recent strategies and developments:
    • 12.4.5.1 Partnerships, Collaborations, and Agreements:
  • 12.4.6 SWOT Analysis
• 12.5 Fujifilm Holdings Corporation
  • 12.5.1 Company Overview
  • 12.5.2 Financial Analysis
  • 12.5.3 Segmental and Regional Analysis
  • 12.5.4 Research & Development Expenses
  • 12.5.5 Recent strategies and developments:
    • 12.5.5.1 Product Launches and Product Expansions:
    • 12.5.5.2 Acquisition and Mergers:
  • 12.5.6 SWOT Analysis
• 12.6 IBM Corporation
  • 12.6.1 Company Overview
  • 12.6.2 Financial Analysis
  • 12.6.3 Regional & Segmental Analysis
  • 12.6.4 Research & Development Expenses
  • 12.6.5 Recent strategies and developments:
    • 12.6.5.1 Product Launches and Product Expansions:
  • 12.6.6 SWOT Analysis
• 12.7 Carestream Health, Inc. (Onex Corporation)
  • 12.7.1 Company Overview
  • 12.7.2 SWOT Analysis
• 12.8 Novarad Enterprise Healthcare Solutions
  • 12.8.1 Company Overview
  • 12.8.2 Recent strategies and developments:
    • 12.8.2.1 Partnerships, Collaborations, and Agreements:
    • 12.8.2.2 Product Launches and Product Expansions:
  • 12.8.3 SWOT Analysis
• 12.9 Canon, Inc. (Canon Medical Systems Corporation)
  • 12.9.1 Company Overview
  • 12.9.2 Financial Analysis
  • 12.9.3 Segmental and Regional Analysis
  • 12.9.4 Research & Development Expenses
  • 12.9.5 Recent strategies and developments:
    • 12.9.5.1 Partnerships, Collaborations, and Agreements:
    • 12.9.5.2 Product Launches and Product Expansions:
  • 12.9.6 SWOT Analysis
• 12.10. INFINITT Healthcare Co. Ltd.
  • 12.10.1 Company Overview
  • 12.10.2 Recent strategies and developments:
    • 12.10.2.1 Partnerships, Collaborations, and Agreements:
    • 12.10.2.2 Product Launches and Product Expansions:
  • 12.10.3 SWOT Analysis

Chapter 13. Winning Imperatives for Vendor Neutral Archive (VNA) & PACS Market